These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells. Alayev A; Berger SM; Kramer MY; Schwartz NS; Holz MK J Cell Biochem; 2015 Mar; 116(3):450-7. PubMed ID: 25336146 [TBL] [Abstract][Full Text] [Related]
3. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells. Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells. Alayev A; Sun Y; Snyder RB; Berger SM; Yu JJ; Holz MK Cell Cycle; 2014; 13(3):371-82. PubMed ID: 24304514 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer. Taniguchi T; Iizumi Y; Watanabe M; Masuda M; Morita M; Aono Y; Toriyama S; Oishi M; Goi W; Sakai T Cell Death Dis; 2016 May; 7(5):e2211. PubMed ID: 27148684 [TBL] [Abstract][Full Text] [Related]
6. S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance. Ghosh J; Kobayashi M; Ramdas B; Chatterjee A; Ma P; Mali RS; Carlesso N; Liu Y; Plas DR; Chan RJ; Kapur R J Clin Invest; 2016 Jul; 126(7):2621-5. PubMed ID: 27294524 [TBL] [Abstract][Full Text] [Related]
8. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells. Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235 [TBL] [Abstract][Full Text] [Related]
9. p53/TAp63 and AKT regulate mammalian target of rapamycin complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damage. Cam M; Bid HK; Xiao L; Zambetti GP; Houghton PJ; Cam H J Biol Chem; 2014 Feb; 289(7):4083-94. PubMed ID: 24366874 [TBL] [Abstract][Full Text] [Related]
10. The mechanism of insulin-stimulated 4E-BP protein binding to mammalian target of rapamycin (mTOR) complex 1 and its contribution to mTOR complex 1 signaling. Rapley J; Oshiro N; Ortiz-Vega S; Avruch J J Biol Chem; 2011 Nov; 286(44):38043-38053. PubMed ID: 21914810 [TBL] [Abstract][Full Text] [Related]
11. S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1. Ben-Hur V; Denichenko P; Siegfried Z; Maimon A; Krainer A; Davidson B; Karni R Cell Rep; 2013 Jan; 3(1):103-15. PubMed ID: 23273915 [TBL] [Abstract][Full Text] [Related]
12. Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway. Havel JJ; Li Z; Cheng D; Peng J; Fu H Oncogene; 2015 Mar; 34(12):1487-98. PubMed ID: 24704832 [TBL] [Abstract][Full Text] [Related]
13. Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1. Völkers M; Toko H; Doroudgar S; Din S; Quijada P; Joyo AY; Ornelas L; Joyo E; Thuerauf DJ; Konstandin MH; Gude N; Glembotski CC; Sussman MA Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12661-6. PubMed ID: 23842089 [TBL] [Abstract][Full Text] [Related]
14. CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation. Roca H; Varsos Z; Pienta KJ J Biol Chem; 2008 Sep; 283(36):25057-73. PubMed ID: 18611860 [TBL] [Abstract][Full Text] [Related]
15. Human chorionic gonadotropin stimulates theca-interstitial cell proliferation and cell cycle regulatory proteins by a cAMP-dependent activation of AKT/mTORC1 signaling pathway. Palaniappan M; Menon KM Mol Endocrinol; 2010 Sep; 24(9):1782-93. PubMed ID: 20660299 [TBL] [Abstract][Full Text] [Related]
16. Stimulatory effect of insulin on theca-interstitial cell proliferation and cell cycle regulatory proteins through MTORC1 dependent pathway. Palaniappan M; Menon B; Menon KM Mol Cell Endocrinol; 2013 Feb; 366(1):81-9. PubMed ID: 23261705 [TBL] [Abstract][Full Text] [Related]
18. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis. Mi W; Ye Q; Liu S; She QB Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827 [TBL] [Abstract][Full Text] [Related]
19. Feedback loops blockade potentiates apoptosis induction and antitumor activity of a novel AKT inhibitor DC120 in human liver cancer. Yang F; Deng R; Qian XJ; Chang SH; Wu XQ; Qin J; Feng GK; Ding K; Zhu XF Cell Death Dis; 2014 Mar; 5(3):e1114. PubMed ID: 24625973 [TBL] [Abstract][Full Text] [Related]
20. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206. Wang H; Huang F; Wang J; Wang P; Lv W; Hong L; Li S; Zhou J Cell Cycle; 2015; 14(2):232-42. PubMed ID: 25607647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]